<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The cytological and cytogenetic features of six patients with myeloid <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and t(6;9)(p23;q34) including a case of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (AMF), a <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), and four cases of <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) are described </plain></SENT>
<SENT sid="1" pm="."><plain>Two patients in this series, both affected by ANLL type M2, presented an increase of bone marrow basophils, suggesting that this cytological-cytogenetic association is not absolute and that it may be more frequently observed in ANLL with maturation </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with de novo ANLL showed associated myelodysplastic features, and one patient presented a <z:e sem="disease" ids="C0026986" disease_type="Neoplastic Process" abbrv="MDS">dysmyelopoietic syndrome</z:e>, later evolving into ANLL </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of the t(6;9) in a range of myeloid <z:hpo ids='HP_0002664'>neoplasias</z:hpo>, with either concurrent myelodysplastic features or a preleukemic phase in cases of ANLL, provide evidence that this chromosome aberration may always involve a multipotent myeloid stem cell </plain></SENT>
<SENT sid="4" pm="."><plain>Data on toxic exposure of the patients suggests that <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> with the t(6;9) may frequently represent environmentally induced <z:hpo ids='HP_0002664'>neoplasias</z:hpo> </plain></SENT>
</text></document>